SPOTLIGHT: Ranbaxy acquires GSK generic business in Spain


In yet another sign of consolidation in the generics business, India's Ranbaxy Laboratories announced that it has acquired the Mundogen generic business of GlaxoSmithKline in Spain. The acquisition is part of Ranbaxy's strategy to bolster its presence in the European markets. Report

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

The 100 largest companies trading on the London Stock Exchange have boosted the percentage of women on their boards, but has life sciences kept pace?

In this week's EuroBiotech Report, Bicycle lands Genentech collaboration, GSK inks COVOD-19 adjuvant deal and Grifols buys antibiotic assets.